|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
1 | AN ACT concerning pseudoephedrine.
| ||||||||||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||||||||
3 | represented in the General Assembly:
| ||||||||||||||||||||||||||||||
4 | Section 5. The Illinois Controlled Substances Act is | ||||||||||||||||||||||||||||||
5 | amended by changing Sections 212 and 216 as follows:
| ||||||||||||||||||||||||||||||
6 | (720 ILCS 570/212) (from Ch. 56 1/2, par. 1212)
| ||||||||||||||||||||||||||||||
7 | Sec. 212. (a) The controlled substances listed in this | ||||||||||||||||||||||||||||||
8 | section are
included in Schedule V.
| ||||||||||||||||||||||||||||||
9 | (b) Any compound, mixture, or preparation containing | ||||||||||||||||||||||||||||||
10 | limited
quantities of any of the following narcotic drugs, or | ||||||||||||||||||||||||||||||
11 | their salts calculated
as the free anhydrous base or alkaloid | ||||||||||||||||||||||||||||||
12 | which also contains
one or more non-narcotic active medicinal | ||||||||||||||||||||||||||||||
13 | ingredients in sufficient
proportion to confer upon the | ||||||||||||||||||||||||||||||
14 | compound, mixture, or preparation,
valuable medicinal | ||||||||||||||||||||||||||||||
15 | qualities other than those possessed by the narcotic
drug alone | ||||||||||||||||||||||||||||||
16 | as set forth below:
| ||||||||||||||||||||||||||||||
17 | (1) not more than 200 milligrams of codeine, or any of | ||||||||||||||||||||||||||||||
18 | its salts,
per 100 milliliters or per 100 grams;
| ||||||||||||||||||||||||||||||
19 | (2) not more than 100 milligrams of dihydrocodeine; or | ||||||||||||||||||||||||||||||
20 | any of its
salts, per 100 milliliters or per 100 grams;
| ||||||||||||||||||||||||||||||
21 | (3) not more than 100 milligrams of ethylmorphine, or | ||||||||||||||||||||||||||||||
22 | any of its
salts, per 100 milliliters or per 100 grams;
| ||||||||||||||||||||||||||||||
23 | (4) not more than 2.5 milligrams of diphenoxylate and | ||||||||||||||||||||||||||||||
24 | not less than
25 micrograms of atropine sulfate per dosage | ||||||||||||||||||||||||||||||
25 | unit;
| ||||||||||||||||||||||||||||||
26 | (5) not more than 100 milligrams of opium per 100 | ||||||||||||||||||||||||||||||
27 | milliliters or per
100 grams;
| ||||||||||||||||||||||||||||||
28 | (6) not more than 0.5 milligram of difenoxin (DEA Drug | ||||||||||||||||||||||||||||||
29 | Code No. 9618)
and not less than 25 micrograms of atropine | ||||||||||||||||||||||||||||||
30 | sulfate per dosage unit.
| ||||||||||||||||||||||||||||||
31 | (c) Buprenorphine.
| ||||||||||||||||||||||||||||||
32 | (d) Pyrovalerone. |
| |||||||
| |||||||
1 | (d-5) Any compound, mixture, or preparation containing any | ||||||
2 | detectable quantity of pseudoephedrine, its salts or optical | ||||||
3 | isomers, or salts of optical isomers.
| ||||||
4 | (e) Any compound, mixture or preparation which contains any | ||||||
5 | quantity
of any controlled substance when such compound, | ||||||
6 | mixture or preparation
is not otherwise controlled in Schedules | ||||||
7 | I, II, III or IV.
| ||||||
8 | (Source: P.A. 89-202, eff. 10-1-95.)
| ||||||
9 | (720 ILCS 570/216)
| ||||||
10 | Sec. 216. Ephedrine.
| ||||||
11 | (a) The following drug products containing ephedrine, its | ||||||
12 | salts, optical
isomers and salts of optical isomers shall be | ||||||
13 | exempt from the application of
Sections 312 and 313 of this Act | ||||||
14 | if they: (i) may lawfully be sold
over-the-counter
without a | ||||||
15 | prescription under the Federal Food, Drug, and Cosmetic Act; | ||||||
16 | (ii) are
labeled and marketed in a manner consistent with | ||||||
17 | Section 341.76 of Title 21 of
the Code of
Federal Regulations; | ||||||
18 | (iii) are
manufactured and distributed for legitimate | ||||||
19 | medicinal use in a manner that
reduces or eliminates the | ||||||
20 | likelihood of abuse; and (iv) are not marketed,
advertised, or | ||||||
21 | labeled for the indications of stimulation, mental alertness,
| ||||||
22 | weight loss, muscle enhancement, appetite control, or energy:
| ||||||
23 | (1) Solid oral dosage forms, including soft gelatin | ||||||
24 | caplets, which are
formulated pursuant to 21 CFR 341 or its | ||||||
25 | successor, and packaged in blister
packs of not more than 2 | ||||||
26 | tablets per blister.
| ||||||
27 | (2) Anorectal preparations containing not more than 5% | ||||||
28 | ephedrine.
| ||||||
29 | (b) The marketing, advertising, or labeling of any product | ||||||
30 | containing
ephedrine, a salt of ephedrine, an optical isomer of | ||||||
31 | ephedrine, or a salt of an
optical isomer of ephedrine, for the | ||||||
32 | indications of stimulation, mental
alertness, weight loss, | ||||||
33 | appetite control, or energy, is prohibited. In
determining | ||||||
34 | compliance with this requirement the Department may consider | ||||||
35 | the
following factors:
|
| |||||||
| |||||||
1 | (1) The packaging of the drug product;
| ||||||
2 | (2) The name and labeling of the product;
| ||||||
3 | (3) The manner of distribution, advertising, and | ||||||
4 | promotion of the product;
| ||||||
5 | (4) Verbal representations made concerning the | ||||||
6 | product;
| ||||||
7 | (5) The duration, scope, and significance of abuse or | ||||||
8 | misuse of the
particular product.
| ||||||
9 | (c) A violation of this Section is a Class A misdemeanor. A | ||||||
10 | second or
subsequent violation of this Section is a Class 4 | ||||||
11 | felony.
| ||||||
12 | (d) This Section does not apply to dietary supplements, | ||||||
13 | herbs, or other
natural products, including concentrates or | ||||||
14 | extracts, which:
| ||||||
15 | (1) are not otherwise prohibited by law; and
| ||||||
16 | (2) may contain naturally occurring ephedrine, | ||||||
17 | ephedrine alkaloids, or
pseudoephedrine, or their salts, | ||||||
18 | isomers, or salts of isomers, or a combination
of these
| ||||||
19 | substances, that:
| ||||||
20 | (i) are contained in a matrix of organic material; | ||||||
21 | and
| ||||||
22 | (ii) do not exceed 15% of the total weight of the | ||||||
23 | natural product. | ||||||
24 | (e) Notwithstanding any other provision of this Section to | ||||||
25 | the contrary, the sale and distribution of any compound, | ||||||
26 | mixture, or preparation containing any detectable quantity of | ||||||
27 | pseudoephedrine, its salts or optical isomers, or salts of | ||||||
28 | optical isomers shall be governed by Section 26 of the | ||||||
29 | Methamphetamine Manufacturing Chemical Retail Sale Control
| ||||||
30 | Act.
| ||||||
31 | (Source: P.A. 90-775, eff. 1-1-99.)
| ||||||
32 | Section 10. The Methamphetamine Manufacturing Chemical | ||||||
33 | Retail Sale Control
Act
is amended by changing Section 35 and | ||||||
34 | by adding Section 26 as follows: |
| |||||||
| |||||||
1 | (720 ILCS 647/26 new) | ||||||
2 | Sec. 26. Pseudoephedrine sales and distribution. | ||||||
3 | (a) If any compound, mixture, or preparation containing any | ||||||
4 | detectable quantity of pseudoephedrine, its salts or optical | ||||||
5 | isomers, or salts of optical isomers is dispensed, sold, or | ||||||
6 | distributed in a pharmacy: | ||||||
7 | (1) the compound, mixture, or preparation shall be | ||||||
8 | dispensed, sold, or distributed only by a pharmacist or a | ||||||
9 | pharmacy technician licensed under the Pharmacy Practice | ||||||
10 | Act of 1987; and | ||||||
11 | (2) any person purchasing, receiving, or otherwise | ||||||
12 | acquiring the compound, mixture, or preparation shall | ||||||
13 | produce a photo identification showing the date of birth of | ||||||
14 | the person and shall sign a written log or receipt showing | ||||||
15 | the date of the transaction, name of the person, and the | ||||||
16 | amount of the compound, mixture, or preparation. | ||||||
17 | (b) A person may not purchase, receive, or otherwise | ||||||
18 | acquire more than 9 grams of any compound, mixture, or | ||||||
19 | preparation containing any detectable quantity of | ||||||
20 | pseudoephedrine, its salts or optical isomers, or salts of | ||||||
21 | optical isomers within any 30-day period. | ||||||
22 | (c) Subsections (a) and (b) of this Section do not apply to | ||||||
23 | any compound, mixture, or preparation containing any | ||||||
24 | detectable quantity of pseudoephedrine, its salts or optical | ||||||
25 | isomers, or salts of optical isomers that are in liquid, liquid | ||||||
26 | capsule, or gel capsule form if pseudoephedrine is not the only | ||||||
27 | active ingredient. | ||||||
28 | (d) The Secretary of Human Services, after consultation | ||||||
29 | with the Director of State Police, may exempt by rule other | ||||||
30 | compounds, mixtures, or preparations containing any detectable | ||||||
31 | quantity of pseudoephedrine, its salts or optical isomers, or | ||||||
32 | salts of optical isomers from the requirements of this Section | ||||||
33 | which the Secretary finds are not used in the illegal | ||||||
34 | manufacture of methamphetamine or other controlled substances. | ||||||
35 | A manufacturer of a drug product containing any detectable | ||||||
36 | quantity of pseudoephedrine, its salts or optical isomers, or |
| |||||||
| |||||||
1 | salts of optical isomers may apply for removal of the product | ||||||
2 | from the requirements of this Section if the product is | ||||||
3 | determined by the Secretary to have been formulated in such a | ||||||
4 | way as to effectively prevent the conversion of the active | ||||||
5 | ingredient into methamphetamine. | ||||||
6 | (720 ILCS 647/35)
| ||||||
7 | Sec. 35. Violations. | ||||||
8 | (a) An individual who violates any provision of this Act , | ||||||
9 | other than Section 26, is guilty of a Class A misdemeanor for a | ||||||
10 | first offense and a Class 4 felony for a second or subsequent | ||||||
11 | offense. An individual who violates Section 26 of this Act is | ||||||
12 | guilty of a Class 4 felony.
| ||||||
13 | (b) Except as provided in subsections (c) and (d) of this | ||||||
14 | Section, the owner and the operator of a retail distributor | ||||||
15 | that violates any provision of this Act are guilty of a | ||||||
16 | business offense and subject to a fine of: | ||||||
17 | (1) $500 for a first offense; | ||||||
18 | (2) $1,000 for a second offense occurring at the same | ||||||
19 | retail location as and within 3 years of the prior offense; | ||||||
20 | and | ||||||
21 | (3) $5,000 for a third or subsequent offense occurring | ||||||
22 | at the same retail location as and within 3 years of the | ||||||
23 | prior offenses.
| ||||||
24 | (c) Any retail distributor that seeks to comply with | ||||||
25 | subsection (c) of Section 15 of this Act by installing | ||||||
26 | automated cash register prompts informing sales employees when | ||||||
27 | the two-package limit described in subsection (c) of Section 15 | ||||||
28 | of this Act has been exceeded shall be subject to all of the | ||||||
29 | penalties described in subsection (b) of this Section except as | ||||||
30 | follows: The owner and the operator of a retail distributor | ||||||
31 | that violates subsection (b) or subsection (c) of Section 30 of | ||||||
32 | this Act are guilty of a business offense and subject to a fine | ||||||
33 | of: | ||||||
34 | (1) $100 for a first offense; | ||||||
35 | (2) $200 for a second offense occurring at the same |
| |||||||
| |||||||
1 | retail location as and within 3 years of the prior offense; | ||||||
2 | (3) $500 for a third or subsequent offense occurring at | ||||||
3 | the same retail location as and within 3 years of the prior | ||||||
4 | offenses; | ||||||
5 | (4) $1,000 for a fourth offense occurring at the same | ||||||
6 | retail location as and within 3 years of the prior | ||||||
7 | offenses; and | ||||||
8 | (5) $5,000 for a fifth offense occurring at the same | ||||||
9 | retail location as and within 3 years of the prior | ||||||
10 | offenses. | ||||||
11 | (d) The owner and the operator of a retail distributor are | ||||||
12 | not liable for any violation of subsection (c) or subsection | ||||||
13 | (e) of Section 15 of this Act if and only if the owner and the | ||||||
14 | operator: | ||||||
15 | (1) strictly complied with subsections (a), (b), and | ||||||
16 | (d) of Section 15 of this Act, Sections 20 and 25 of this | ||||||
17 | Act, and subsection (a) of Section 30 of this Act; | ||||||
18 | (2) made a good-faith effort to ensure compliance with | ||||||
19 | subsections (c) and (e) of Section 15 of this Act; | ||||||
20 | (3) made a good-faith effort to comply with subsection | ||||||
21 | (b) and subsection (c) of Section 30 of this Act; and | ||||||
22 | (4) had no advance knowledge of the violation or | ||||||
23 | violations in question and did not act in reckless | ||||||
24 | disregard of the likelihood of such violation or | ||||||
25 | violations.
| ||||||
26 | (Source: P.A. 93-1008, eff. 1-1-05.)
| ||||||
27 | Section 99. Effective date. This Act takes effect upon | ||||||
28 | becoming law.
|